Biosynex (ALBIO) — Long-term Investment Intensity
Biosynex (ALBIO) has a Long-term Investment Intensity of 1.4% as of June 2019. Long-term investments of €561.94K represent 1.4% of total assets of €40.31 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Biosynex asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Biosynex Long-term Investment Intensity (2013–2018)
This chart shows how Biosynex's Long-term Investment Intensity has evolved across 6 annual periods from 2013 to 2018. As of June 2019, the intensity stands at 1.4%, reflecting long-term investments of €561.94K against total assets of €40.31 Million EUR. For the complete balance sheet picture, see Biosynex total assets.
Annual Long-term Investment Intensity for Biosynex (2013–2018)
The table below presents the year-by-year Long-term Investment Intensity for Biosynex from 2013 to 2018, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Biosynex balance sheet liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 1.4% | €543.79K | €39.46 Million | ▼ -1.4 pp |
| 2017 | 2.7% | €1.11 Million | €40.51 Million | ▲ +0.8 pp |
| 2016 | 2.0% | €775.54K | €39.51 Million | ▼ -36.9 pp |
| 2015 | 38.9% | €10.87 Million | €27.95 Million | ▲ +11.8 pp |
| 2014 | 27.1% | €1.84 Million | €6.79 Million | ▼ -7.7 pp |
| 2013 | 34.7% | €2.54 Million | €7.31 Million | — |